Brick&Bolt
India
- Bengaluru, Karnataka
- 10/01/2023
- Series A
- $10,000,000
Brick&Bolt is an e-commerce platform that uses cutting-edge technology and state-of-the-art systems and processes to make home and commercial construction absolutely simple, transparent and reliable for customers.
We are a pre-series A funded company by Sequoia Surge.
Usually the entire experience of construction – from finding the right professionals, to the right price and the optimal timelines – tends to be opaque and a huge drain on resources and time.
Brick&Bolt’s tech-based construction platform makes this process seamless by connecting customers to a curated set of service providers, enabling transparent pricing, managing projects to ensure adherence to approved quality & timelines and also levying penalties on the service providers in case of any delay. The process is augmented by an AI based engine predicting the work schedules and managing quality & progress of projects using computer vision.
Brick&Bolt also secured Rs 16.5 crore in its Series A funding round from Foundamental GmBh. This is the second investment round for the company in 2020. -https://entrackr.com/2020/08/brickbolt-scores-series-a-round
Contact us for:
Any Info @
email : info@bricknbolt.com
Ph : +91 7505 205 205
Jobs @
dharani.santhosh@bricknbolt.com
Ph No: +91 82174 25943
Customer Queries @
care@bricknbolt.com
Ph : +91 7505 205 205
- Industry Technology, Information and Internet
- Website https://www.bricknbolt.com/
- LinkedIn https://www.linkedin.com/company/bricknbolt/
Related People
Jayesh RajpurohitCo Founder
India -
Bengaluru, Karnataka
Like to solve highly complex problems using technology.
Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)